Ligand Pharmaceuticals (NASDAQ:LGND) Posts Earnings Results, Beats
Estimates By $3.01 EPS
-
Ligand Pharmaceuticals (NASDAQ:LGND – Get Free Report) released its
quarterly earnings results on Tuesday. The biotechnology company reported
$3.84 earning...
15 minutes ago